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Since	chikungunya	virus	 (CHIKV)	was	 introduced	 into	 the	
Americas	 in	 2013,	 its	 geographic	 distribution	 has	 rapidly	
expanded.	Of	 119	 serum	samples	 collected	 in	 2014	 from	
febrile	patients	 in	southern	Mexico,	79%	were	positive	 for	
CHIKV	 or	 IgM	 against	 CHIKV.	 Sequencing	 results	 con-
firmed	CHIKV	strains	closely	related	to	Caribbean	isolates.
Chikungunya virus (CHIKV), an arbovirus in genus Al-phavirus, family Togaviridae, has undergone a rapid 
geographic expansion during the past decade (1). CHIKV 
is the causative agent of chikungunya fever, which may be 
accompanied by severe, debilitating, and even chronic ar-
thralgia. During urban outbreaks, CHIKV uses the highly 
susceptible and anthropophilic Aedes aegypti and A. al-
bopictus mosquitoes as vectors, which results in high at-
tack rates (1).
The West African and East/Central/South African 
(ECSA) CHIKV lineages, the 2 most ancient enzootic 
lineages, primarily circulate in sub-Saharan Africa. Over 
the past century, the ECSA lineage has given rise to the 
Asian lineage, found in urban cycles in India and Southeast 
Asia, and later to the Indian Ocean lineage, which emerged 
from Kenya into the Indian Ocean Basin in 2004 (1). In 
late 2013, an outbreak of chikungunya fever caused by an 
Asian lineage strain began in the Caribbean island of St. 
Martin (2,3). During 2014, CHIKV spread throughout the 
Caribbean and into Latin America, causing epidemics in 
South and Central America, while also causing sporadic 
autochthonous cases in North America (1). The importa-
tion from Angola and local circulation of an ECSA strain 
was also recently reported in Brazil (4), which now has 2 
CHIKV lineages circulating. The total number of suspect-
ed cases in the Americas now exceeds 1.6 million and is 
steadily rising (3,5).
In October 2014, physicians in Chiapas State, Mexico, 
noticed large numbers of patients reporting febrile illness 
accompanied by rash and an unusual arthralgia, and chi-
kungunya fever was suspected. Here we report a chikungu-
nya fever outbreak in southern Mexico, involving CHIKV 
of Asian lineage as the etiologic agent.
The Study
To ascertain the etiologic agent causing an outbreak of fe-
brile illness with symptoms similar to chikungunya fever, 
we selected 3 sites in Chiapas State, Mexico, for sampling: 
Tapachula, La Libertad, and Ciudad Hidalgo (Figure 1, 
panel A). After patients’ informed consent was obtained, 
blood samples were collected from persons whose condi-
tion met the following case definition for possible chikun-
gunya fever: acute onset of fever >38.5°C, accompanied 
by severe arthralgia not explained by other medical con-
ditions (6). Samples from Tapachula were collected from 
patients who sought treatment at the Centro Regional de 
Investigacion en Salud Publica, whereas in La Libertad 
and Ciudad Hidalgo, researchers surveyed houses to iden-
tify potential case-patients. In total, 119 blood samples 
were collected, and serum was isolated by centrifugation. 
Six samples were stored in MagnaPure LC buffer (Roche, 
Nutley, NJ, USA), which inactivates virus particles but 
preserves the genomic RNA.
Viral RNA was extracted from serum samples using 
the ZR-96 Viral RNA Kit (Zymo Research, Orange, CA, 
USA) according to the manufacturer’s protocol. One-step 
quantitative reverse transcription PCR (qRT-PCR) (7) was 
performed by using the TaqMan RNA-to-Ct 1-step Kit 
(Applied Biosystems, San Francisco, CA, USA). Standard 
plaque assays were performed for the samples positive 
by qRT-PCR with Vero cells. Anti-CHIKV IgM-capture 
enzyme-linked immunosorbent assays (ELISAs) (8) were 
performed by using a chimeric Eilat-CHIKV (9) that 
contained the nonstructural proteins from Eilat virus and 
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structural proteins from CHIKV, resulting in a structure 
indistinguishable from that of CHIKV. Plaque-reduction 
neutralization tests were used to confirm ELISA results. A 
sample was considered to be CHIKV negative if the sample 
was not positive by qRT-PCR or IgM ELISA.
Viral RNA from 5 serum samples was sent for Illumina 
deep sequencing and assembled by using the virus-specific 
HIVE-Hexagon algorithm (10) and the NGen module in 
Lasergene Suite version 10 (Bioinformatics Pioneer DNA-
Star, Inc., Madison, WI, USA ). Single nucleotide poly-
morphisms were analyzed by using the sequencing profil-
ing tool in the HIVE suite of programs (10). Sequences 
were aligned in SeaView (11) by using translated proteins 
for the open reading frames and using nucleotides for the 
untranslated genome regions, and all gaps were removed. 
Bayesian phylogenetic inference was performed by using 
the general time reversible plus invariant sites plus gamma 
distribution 4 model in MrBayes (12) with 1.5 million it-
erations to reach congruence. Partial genome sequencing 
of the E2 and E1 glycoproteins was performed by using 
traditional Sanger methods on PCR amplicons on an ad-
ditional 8 samples.
Over 100 serum samples were obtained from persons 
seeking treatment for chikungunya fever–like illness dur-
ing October–December 2014 in 3 locations in Chiapas, 
Mexico (Tapachula, La Libertad, Ciudad Hidalgo) (Fig-
ure 1). These samples were analyzed by qRT-PCR and 
IgM-capture ELISA to detect viremia and IgM, respec-
tively. No overlap occurred between the samples that 
were positive for CHIKV by qRT-PCR or those positive 
by IgM, demonstrating the importance of the humoral re-
sponse to viral clearance. With few exceptions, viremia 
was detectable up to 3 days after fever onset (Figure 2, 
panel A), after which most samples were IgM positive. 
All age groups were equally likely to be infected, as ex-
pected during infectious disease outbreaks involving a 
naive population (13). 
Plaque assays were performed to determine serum 
virus titers (Table); 3 qRT-PCR samples from Tapachula 
could not be assayed because of sample limitations. Mean 
Figure 1.	Map	of	Mexico	
showing	the	3	sites	where	serum	
samples	were	obtained	to	test	for	
chikungunya	virus	in	Chiapas,	
Mexico,	2014:	Tapachula,	La	
Libertad,	and	Ciudad	Hidalgo.	
 
 
 
Table. Proportions	of	CHIKV	viremia	and	IgM	in	119	serum	samples	collected	at 3 collection	sites in	Chiapas,	Mexico,	October–
December	2014* 
Collection	site No.	serum	samples 
%	qRT-PCR	positive	
serum	samples	(no.) 
Mean	serum	virus	titer, log10 
PFU/mL (SD) 
%	IgM-positive	serum	
samples† (no.) 
La	Libertad 43 20	(9) 3.26 (0.57) 51.2	(22) 
Ciudad	Hidalgo 63 23.8	(15) 3.36 (0.56) 68.2	(43) 
Tapachula 13 30.8	(4) 3.66 7.7	(1) 
*CHIKV,	chikungunya	virus;	qRT-PCR, quantitative	reverse	transcription	PCR. 
†Six patient samples	that	were	negative	for	CHIKV	by	qRT-PCR	were	unable	to	be	used	for	plaque	assays	or	ELISAs	because	they	were	stored in 
MagnaPure	Buffer (Roche,	Nutley,	NJ,	USA). 
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viremia level was similar among the 3 sampled locations 
and ranged from <2 log
10
 to 4.2 log
10
 PFU/mL.
Five serum samples from diverse locations and collec-
tion dates were selected for Illumina sequencing (GenBank 
accession nos. KT327163–KT327167). The strains circulat-
ing in Chiapas were most closely related to Asian lineage 
strains first detected in the Caribbean (represented by a Brit-
ish Virgin Islands isolate) and now presumed to be circulat-
ing in much of Latin America (Figure 2, panel B). Curi-
ously, no novel mutations appear to have been fixed in the 
year since the British Virgin Islands isolate was collected.
Although the genomic sequences confirmed that the 
circulating virus in Chiapas belonged to the Asian lin-
eage, which is primarily transmitted by A. aegypti mos-
quitoes (1), we nevertheless examined the sequences for 
mutations known to adapt CHIKV for transmission by A. 
albopictus mosquitoes. Because both mosquito species 
are found in Chiapas (14), adaptation of the CHIKV strain 
circulating in Mexico to A. albopictus mosquitoes could 
place temperate regions of the eastern United States and 
millions of naive persons at risk for infection. None of 
the E2 or E1 substitutions previously reported to increase 
Figure 2.	A)	Number	of	serum	
samples	positive	for	chikungunya	
virus	(CHIKV)	by	reverse	
transcription	quantitative	PCR	
(qRT-PCR),	for	CHIKV	IgM	by	
ELISA,	and	negative	for	CHIKV	
by	both	methods,	arranged	
according	to	day	after	fever	
onset.	B)	Phylogenetic	tree	
generated	by	Bayesian	analysis	
showing	the	relationship	of	the	
complete	genomic	sequences	
of	5	chikungunya	virus	isolates	
from	Mexico	and	representative	
sequences	from	the	GenBank	
library.	All	nodes	showed	posterior	
probabilities	of	>0.9,	except	those	
indicated	with	a	star.	The	inset	
shows	the	closest	relatives	of	the	5	
isolates.	ECSA,	East/Central/South	
African,	IOL,	Indian	Ocean	lineage.	
Scale	bar	indicates	nucleotide	
substitutions	per	site.	
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fitness in A. albopictus mosquitoes was observed in 8 ad-
ditional samples analyzed by Sanger sequencing (Gen-
Bank accession nos. KT247378–KT247385) (15). One 
sample had a nonsynonymous mutation, in comparison to 
the January 2014 British Virgin Islands isolate (GenBank 
accession no. KJ451624) that encoded E1-V7M, which 
had not previously been described.
Conclusions
We found that 79% of febrile illness cases with polyar-
thralgia in Chiapas State during late 2014 were caused by 
CHIKV. Our sequencing of CHIKV genomes confirmed 
spread of an Asian lineage strain from the Caribbean and 
suggested that although CHIKV has circulated in the 
Americas since 2013, no adaptive mutations have oc-
curred. However, continued screening for vector-adaptive 
mutations will be critical, especially now that strains of 
the ECSA lineage, which gave rise to the Indian Ocean 
lineage, have been introduced into Brazil (4).
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